These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11030492)

  • 41. What's in a name?
    Damodoran SS
    Aust N Z J Psychiatry; 2000 Aug; 34(4):698-9. PubMed ID: 10954408
    [No Abstract]   [Full Text] [Related]  

  • 42. Quetiapine: a review of its safety in the management of schizophrenia.
    Dev V; Raniwalla J
    Drug Saf; 2000 Oct; 23(4):295-307. PubMed ID: 11051217
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms.
    Riedel M; Müller N; Strassnig M; Spellmann I; Engel RR; Musil R; Dehning S; Douhet A; Schwarz MJ; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2005 Dec; 255(6):432-7. PubMed ID: 16267634
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quetiapine and QTc issues: a case report.
    Gupta S; Nienhaus K; Shah SA
    J Clin Psychiatry; 2003 May; 64(5):612-3. PubMed ID: 12755671
    [No Abstract]   [Full Text] [Related]  

  • 45. A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy.
    Kapur S; Zipursky R; Jones C; Shammi CS; Remington G; Seeman P
    Arch Gen Psychiatry; 2000 Jun; 57(6):553-9. PubMed ID: 10839333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Delusions associated with quetiapine-related weight redistribution.
    Wirshing DA; Boyd JA; Pierre JM; Saunders CS; Wirshing WC; Azizian K; Patel KR; Ashcraft JC; Darmandjian H; Feusner J
    J Clin Psychiatry; 2002 Mar; 63(3):247-8. PubMed ID: 11926726
    [No Abstract]   [Full Text] [Related]  

  • 47. Characterization of the effects of receptor-selective ligands in rats discriminating the novel antipsychotic quetiapine.
    Goudie AJ; Smith JA; Millan MJ
    Psychopharmacology (Berl); 2004 Jan; 171(2):212-22. PubMed ID: 14691616
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antipsychotic drugs and schizophrenia.
    Essock SM; Covell NH; Jackson CT
    N Engl J Med; 2006 Jan; 354(3):298-300; author reply 298-300. PubMed ID: 16422020
    [No Abstract]   [Full Text] [Related]  

  • 49. Successful quetiapine treatment in a schizophrenic patient with polydipsia and dyskinesia: a case report.
    Caykoylu A; Ekinci O; Albayrak Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1557-8. PubMed ID: 19733605
    [No Abstract]   [Full Text] [Related]  

  • 50. Quetiapine for schizophrenia.
    Med Lett Drugs Ther; 1997 Dec; 39(1016):117-8. PubMed ID: 9422044
    [No Abstract]   [Full Text] [Related]  

  • 51. Thrombocytopenia secondary to the use of quetiapine.
    Handoo I; Perales M; Klaus N; Khan AY
    J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):453-5. PubMed ID: 20973718
    [No Abstract]   [Full Text] [Related]  

  • 52. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
    Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
    Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Severe hyperlipidemia associated with olanzapine and quetiapine use.
    Carnahan RM; Reantaso AA; Teegarden BA; Pogue T
    Am J Psychiatry; 2007 Oct; 164(10):1614-5. PubMed ID: 17898359
    [No Abstract]   [Full Text] [Related]  

  • 54. [Sexual disturbances during the treatment with neuroleptics in patients with schizophrenia and schizophrenia spectrum disorders].
    Iagubov MI; Shtark LN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(9 Pt 2):57-60. PubMed ID: 22027609
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quetiapine and leukopenia.
    Clark N; Weissberg E; Noel J
    Am J Psychiatry; 2001 May; 158(5):817-8. PubMed ID: 11329413
    [No Abstract]   [Full Text] [Related]  

  • 56. Atypical antipsychotics, improved intrusive symptoms in patients with posttraumatic stress disorder.
    Ahearn EP; Winston E; Mussey M; Howell T
    Mil Med; 2003 Sep; 168(9):x-xi. PubMed ID: 14529262
    [No Abstract]   [Full Text] [Related]  

  • 57. Agranulocytosis and granulocytopenia associated with quetiapine.
    Ruhé HG; Becker HE; Jessurun P; Marees CH; Heeringa M; Vermeulen HD
    Acta Psychiatr Scand; 2001 Oct; 104(4):311-3; discussion 313-4. PubMed ID: 11722307
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Re: Neuroleptic malignant syndrome associated with quetiapine.
    Karagianis J; Phillips L; Hogan K; LeDrew K
    Can J Psychiatry; 2001 May; 46(4):370-1. PubMed ID: 11387795
    [No Abstract]   [Full Text] [Related]  

  • 59. FDA panel OKs 3 antipsychotic drugs for pediatric use, cautions against overuse.
    Kuehn BM
    JAMA; 2009 Aug; 302(8):833-4. PubMed ID: 19706851
    [No Abstract]   [Full Text] [Related]  

  • 60. The pharmacology of weight gain with antipsychotics.
    Casey DE; Zorn SH
    J Clin Psychiatry; 2001; 62 Suppl 7():4-10. PubMed ID: 11346195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.